HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kosaki, A. Articles by Webster, N. J. G. Search for Related Content PubMed PubMed Citation Articles by Kosaki, A. Articles by Webster, N. J. G. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 17, 10331-10337, April 24, 1998

Identification of Intron and Exon Sequences Involved in Alternative Splicing of Insulin Receptor Pre-mRNA

From the Medical Research Service, Department of Veterans Affairs Medical Center, San Diego, California 92161 and the UCSD Cancer Center and the UCSD/Whittier Diabetes Research Program, Department of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, La Jolla, California 92093

The insulin receptor exists as two isoforms, A and B, that result from alternative splicing of exon 11 in the primary transcript. We have shown previously that the alternative splicing is developmentally and hormonally regulated. Consequently, these studies were instigated to identify sequences within the primary RNA transcript that regulate the alternative splicing. Minigenes containing exons 10, 11, and 12 and the intervening introns were constructed and transfected into HepG2 cells, which contain both isoforms of the insulin receptor. The cells were able to splice the minigene transcript to give both A ( exon 11) and B-like (+ exon 11) RNAs. A series of internal deletions within intron 10 were tested for their ability to give A and B RNAs. Intron 10 contained two sequences that modulated exon 11 inclusion; a 48-nucleotide purine-rich sequence at the 5' end of intron 10 that functions as a splicing enhancer and causes an increase in exon 11 inclusion, and a 43-nucleotide sequence at the 3' end of intron 10 upstream of the branch point sequence that favors skipping of exon 11. Increasing the length of the polypyrimidine tract at the 3' end of intron 10 caused exon 11 to be spliced constitutively, indicating that a weak splice site is required for alternative splicing. Finally, point mutations, insertions, and deletions within exon 11 itself were able to regulate inclusion of the exon both positively and negatively.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. Sen, I. Talukdar, and N. J. G. Webster SRp20 and CUG-BP1 Modulate Insulin Receptor Exon 11 Alternative Splicing Mol. Cell. Biol., February 1, 2009; 29(3): 871 - 880. [Abstract] [Full Text] [PDF]

				A. Navarrete Santos, N. Ramin, S. Tonack, and B. Fischer Cell Lineage-Specific Signaling of Insulin and Insulin-Like Growth Factor I in Rabbit Blastocysts Endocrinology, February 1, 2008; 149(2): 515 - 524. [Abstract] [Full Text] [PDF]

				T. H. Ho, R. S. Savkur, M. G. Poulos, M. A. Mancini, M. S. Swanson, and T. A. Cooper Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy J. Cell Sci., July 1, 2005; 118(13): 2923 - 2933. [Abstract] [Full Text] [PDF]

				N. A. Patel, S. Kaneko, H. S. Apostolatos, S. S. Bae, J. E. Watson, K. Davidowitz, D. S. Chappell, M. J. Birnbaum, J. Q. Cheng, and D. R. Cooper Molecular and Genetic Studies Imply Akt-mediated Signaling Promotes Protein Kinase C{beta}II Alternative Splicing via Phosphorylation of Serine/Arginine-rich Splicing Factor SRp40 J. Biol. Chem., April 8, 2005; 280(14): 14302 - 14309. [Abstract] [Full Text] [PDF]

				W. Dansithong, S. Paul, L. Comai, and S. Reddy MBNL1 Is the Primary Determinant of Focus Formation and Aberrant Insulin Receptor Splicing in DM1 J. Biol. Chem., February 18, 2005; 280(7): 5773 - 5780. [Abstract] [Full Text] [PDF]

				J. Kralovicova, S. Houngninou-Molango, A. Kramer, and I. Vorechovsky Branch site haplotypes that control alternative splicing Hum. Mol. Genet., December 15, 2004; 13(24): 3189 - 3202. [Abstract] [Full Text] [PDF]

				A. N. Ladd, N. H. Nguyen, K. Malhotra, and T. A. Cooper CELF6, a Member of the CELF Family of RNA-binding Proteins, Regulates Muscle-specific Splicing Enhancer-dependent Alternative Splicing J. Biol. Chem., April 23, 2004; 279(17): 17756 - 17764. [Abstract] [Full Text] [PDF]

				N. A. Patel, H. S. Apostolatos, K. Mebert, C. E. Chalfant, J. E. Watson, T. S. Pillay, J. Sparks, and D. R. Cooper Insulin Regulates Protein Kinase C{beta}II Alternative Splicing in Multiple Target Tissues: Development of a Hormonally Responsive Heterologous Minigene Mol. Endocrinol., April 1, 2004; 18(4): 899 - 911. [Abstract] [Full Text] [PDF]

				B. K. Ray, R. Murphy, P. Ray, and A. Ray SAF-2, a Splice Variant of SAF-1, Acts as a Negative Regulator of Transcription J. Biol. Chem., November 22, 2002; 277(48): 46822 - 46830. [Abstract] [Full Text] [PDF]

				M. Deguillien, S.-C. Huang, M. Moriniere, N. Dreumont, E. J. Benz Jr, and F. Baklouti Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation Blood, December 15, 2001; 98(13): 3809 - 3816. [Abstract] [Full Text] [PDF]

				H. Lou and R. F. Gagel Alternative Ribonucleic Acid Processing in Endocrine Systems Endocr. Rev., April 1, 2001; 22(2): 205 - 225. [Abstract] [Full Text]

				M. L. Hastings, H. A. Ingle, M. A. Lazar, and S. H. Munroe Post-transcriptional Regulation of Thyroid Hormone Receptor Expression by cis-Acting Sequences and a Naturally Occurring Antisense RNA J. Biol. Chem., April 6, 2000; 275(15): 11507 - 11513. [Abstract] [Full Text] [PDF]

				I. Kacskovics, Z. Wu, N. E. Simister, L. V. Frenyo, and L. Hammarstrom Cloning and Characterization of the Bovine MHC Class I-Like Fc Receptor J. Immunol., February 15, 2000; 164(4): 1889 - 1897. [Abstract] [Full Text] [PDF]

				F. Frasca, G. Pandini, P. Scalia, L. Sciacca, R. Mineo, A. Costantino, I. D. Goldfine, A. Belfiore, and R. Vigneri Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells Mol. Cell. Biol., May 1, 1999; 19(5): 3278 - 3288. [Abstract] [Full Text] [PDF]